Equus Innovations, a manufacturer of advanced, next-generation veterinary regenerative products, in partnership with AlphaLogix, LLC (Argyle, Texas) announced today successful market release of a new canine allograft, AlphaFlo®.
CASE STUDY: Oral Squamous Cell Carcinoma
Case Presentation: On February 8, 2024, an 8-year-old, spayed female Doberman Pinscher presented with a mass on the right craniolateral mandible. Biopsy samples revealed a squamous cell carcinoma. At the discretion of the veterinarian, 2.0 cc of AlphaFlo® was...